Reposal

Jump to: navigation, search
Reposal
Reposal.png
Clinical data
SynonymsReposal, 5-Ethyl-5-(bicyclo(3.2.1)octenyl)barbituric acid
ATC code
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC14H18N2O3
Molar mass262.304 g/mol

WikiDoc Resources for Reposal

Articles

Most recent articles on Reposal

Most cited articles on Reposal

Review articles on Reposal

Articles on Reposal in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Reposal

Images of Reposal

Photos of Reposal

Podcasts & MP3s on Reposal

Videos on Reposal

Evidence Based Medicine

Cochrane Collaboration on Reposal

Bandolier on Reposal

TRIP on Reposal

Clinical Trials

Ongoing Trials on Reposal at Clinical Trials.gov

Trial results on Reposal

Clinical Trials on Reposal at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Reposal

NICE Guidance on Reposal

NHS PRODIGY Guidance

FDA on Reposal

CDC on Reposal

Books

Books on Reposal

News

Reposal in the news

Be alerted to news on Reposal

News trends on Reposal

Commentary

Blogs on Reposal

Definitions

Definitions of Reposal

Patient Resources / Community

Patient resources on Reposal

Discussion groups on Reposal

Patient Handouts on Reposal

Directions to Hospitals Treating Reposal

Risk calculators and risk factors for Reposal

Healthcare Provider Resources

Symptoms of Reposal

Causes & Risk Factors for Reposal

Diagnostic studies for Reposal

Treatment of Reposal

Continuing Medical Education (CME)

CME Programs on Reposal

International

Reposal en Espanol

Reposal en Francais

Business

Reposal in the Marketplace

Patents on Reposal

Experimental / Informatics

List of terms related to Reposal

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Reposal is a barbiturate derivative invented in the 1960s in Denmark. It has sedative, hypnotic and anticonvulsant properties, and was used primarily for the treatment of insomnia. [1] [2]



References

  1. Kessing SV, Tarding F, Thomsen AC. Reposal, A New Hypnotic. (Danish) Ugeskrift for Læger. 1963 Dec 6;125:1735-1741.
  2. Nielsen P, Tarding F. The metabolic fate of 5-(bicyclo-3,2,1,-oct-2-en-2-yl)-5-ethyl barbituric acid, (Reposal). Acta Pharmacologica et Toxicologica (Copenhagen). 1968;26(6):521-30.



Linked-in.jpg